UnknownPhase 4NCT02624830
Long-Term Sulfonylurea Response in ABCC8 Neonatal Diabetes (SuResponsSUR)
Studying Neonatal diabetes mellitus
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Haukeland University Hospital
- Principal Investigator
- Pål Rasmus Njølstad, MD, PhDHaukeland University Hospital
- Intervention
- Sulfonylurea(drug)
- Enrollment
- 30 target
- Eligibility
- 9-95 years · All sexes
- Timeline
- 2019 – 2020
Study locations (1)
- Haukeland University Hospital, Bergen, Norway
Collaborators
University of Bergen · University of Exeter · Royal Devon and Exeter NHS Foundation Trust · Institut National de la Santé Et de la Recherche Médicale, France · Hôpital Necker-Enfants Malades · University of Rome Tor Vergata
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02624830 on ClinicalTrials.govOther trials for Neonatal diabetes mellitus
Additional recruiting or active studies for the same condition.